Prevention of Cholangitis by Spontaneously Dislodging Biliary Stent After an Endoscopic Procedure in Patients With Asymptomatic Bile Duct Stones
DEN Open · 2026-04 · 6 (1)
DOI: 10.1002/deo2.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift DEN Open, online erschienen am 23.08.2025. Verfasst von Shinichi Nihei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology Yokohama City University Kanagawa Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the effectiveness of spontaneously dislodging biliary stent (SDBS) placement in preventing acute cholangitis after endoscopic retrograde cholangiopancreatography (ERCP) in patients with asymptomatic bile duct stones.
Methods
This retrospective, single‐center study included 63 patients (mean age, 73 ± 11 years; 43 men) who underwent ERCP for asymptomatic bile duct stones at our institute between April 2022 and May 2024; they were categorized into the SDBS (33 patients) and non‐stent (30 patients) groups. Stone removal was performed in all cases, and complete stone clearance was achieved. Post‐procedure cholangitis was diagnosed based on the Tokyo Guidelines 2018. The primary endpoint was post‐procedural acute cholangitis on day one. Secondary endpoints included cholangitis‐related factors, type of device used, procedure time, and adverse events other than cholangitis. Multivariate analysis was performed to identify factors associated with post‐procedure cholangitis.
Results
No significant differences were observed in prior cholecystectomy, bile duct diameter, or the number of stones between the two groups. The overall incidence of post‐procedure cholangitis was 17.4%. The incidence was significantly lower in the SDBS group than in the non‐stent group (6% vs. 30%; p = 0.01). No significant differences were observed in procedure time, incidence of complications such as post‐ERCP pancreatitis, or postoperative hospital stay between the SDBS and non‐stent groups. Multivariate analysis identified the absence of an SDBS (odds ratio, 6.09; 95% confidence interval, 1.04–35.6, p = 0.04) as an independent factor associated with post‐procedure cholangitis.
Conclusion
SDBS placement may be effective in preventing cholangitis after ERCP in asymptomatic patients with bile duct stones.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology Yokohama City University Kanagawa Japan.
ORCID-Profile: Sho Hasegawa, Yusuke Kurita, Kensuke Kubota
Zitieren
APA
Nihei, S., Hasegawa, S., Honda, Y., Yamazaki, Y., Iizuka, T., Kurita, Y., Hosono, K., Yoneda, M., Kubota, K., & Nakajima, A. (2026). Prevention of Cholangitis by Spontaneously Dislodging Biliary Stent After an Endoscopic Procedure in Patients With Asymptomatic Bile Duct Stones. DEN Open, 6(1). https://doi.org/10.1002/deo2.70194
Vancouver
Nihei S, Hasegawa S, Honda Y, Yamazaki Y, Iizuka T, Kurita Y, et al. Prevention of Cholangitis by Spontaneously Dislodging Biliary Stent After an Endoscopic Procedure in Patients With Asymptomatic Bile Duct Stones. DEN Open. 2026;6(1). doi:10.1002/deo2.70194
BibTeX
@article{Nihei2026,
author = {Nihei, Shinichi and Hasegawa, Sho and Honda, Yu and Yamazaki, Yuma and Iizuka, Takeshi and Kurita, Yusuke and Hosono, Kunihiro and Yoneda, Masato and Kubota, Kensuke and Nakajima, Atsushi},
title = {Prevention of Cholangitis by Spontaneously Dislodging Biliary Stent After an Endoscopic Procedure in Patients With Asymptomatic Bile Duct Stones},
journal = {DEN Open},
year = {2026},
volume = {6},
number = {1},
doi = {10.1002/deo2.70194}
}
EUVIMED